Dataset Information

Dispositions and tissue residue of zearalenone and its metabolites ?-zearalenol and ?-zearalenol in broilers.

ABSTRACT: Zearalenone (ZEA) is a secondary fungal metabolite produced mainly by a Fusarium graminearum. To clarify the toxicokinetics, and residues of ZEA and its major metabolites ?-zearalenol (?-ZOL) and ?-zearalenol (?-ZOL) in chickens, ZEA was then administered intravenously (iv) or orally (po) to broiler chickens at a dosage of 1.2 mg/kg body weight. The concentrations of ZEA, ?-ZOL and ?-ZOL in the plasma and various tissues were quantified using LC-MS/MS. The plasma concentrations of ZEA were measurable up to 2 h after iv and po administration, and the concentrations of ?-ZOL and ?-ZOL were detected up to 4 h after both types of administration. A two-compartment model was developed to describe the toxicokinetic of ZEA in broilers. The values of t_1/2? and V_d were 1.36 ± 0.29 h and 6.40 ± 0.89 l/kg, respectively. The absolute oral bioavailability was 29.66 ± 5.6%. ZEA, ?-ZOL and ?-ZOL were measurable in the vital organs after po administration. These results suggest that ZEA is absorbed from the gastrointestinal tract and it has ability to penetrate into the various tissues of broiler chickens.

SUBMITTER: Buranatragool K

PROVIDER: S-EPMC5598537 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Dispositions and tissue residue of zearalenone and its metabolites α-zearalenol and β-zearalenol in broilers.

Buranatragool Kawinnart K Poapolathep Saranya S Isariyodom Supaporn S Imsilp Kanjana K Klangkaew Narumol N Poapolathep Amnart A

Toxicology reports 20150102

Zearalenone (ZEA) is a secondary fungal metabolite produced mainly by a <i>Fusarium graminearum</i>. To clarify the toxicokinetics, and residues of ZEA and its major metabolites α-zearalenol (α-ZOL) and β-zearalenol (β-ZOL) in chickens, ZEA was then administered intravenously (iv) or orally (po) to broiler chickens at a dosage of 1.2 mg/kg body weight. The concentrations of ZEA, α-ZOL and β-ZOL in the plasma and various tissues were quantified using LC-MS/MS. The plasma concentrations of ZEA wer ...[more]

PMID: 28962368

Similar Datasets

Project description:Risk assessment primarily relies on toxicological data of individual substances, with limited information on combined effects. Recent in vitro experiments using Ishikawa cells, an endometrial carcinoma cell line expressing both estrogen receptor isoforms, demonstrated interactive effects of phyto- and mycoestrogens. The mycoestrogens, zearalenone (ZEN), and α-zearalenol (α-ZEL) exhibited significantly enhanced estrogenic responses in the presence of isoflavones (ISF), depending on substance ratios and concentrations. This study investigated the impact of phyto- and mycoestrogen combinations on estrogenic response following OECD guideline 455, utilizing hERα-HeLa-9903 cells. Test substances included mycoestrogens (ZEN and α-ZEL) and isoflavones (genistein (GEN), daidzein (DAI), and S-equol (EQ), a gut microbial metabolite of DAI). Mycoestrogens were tested in the range of 0.001 to 100 nM, while isoflavones were used at concentrations 1000 times higher based on relevant occurrence ratios. Results showed that ZEN and α-ZEL induced ERα-dependent luciferase expression in concentrations above 1 nM and 0.01 nM, respectively. However, ISF caused a superinduction of the luciferase signal above 1 µM. A superinduction is characterized by an unusually strong or heightened increase in the activity of the luciferase enzyme. This signal is not affected by the estrogen receptor antagonist 4-hydroxytamoxifen (4-OH-TAM), which was additionally used to verify whether the increase of signal is a true reflection of receptor activation. This superinduction was observed in all combinations of ZEN and α-ZEL with ISFs. Contrary to the luciferase activity findings, RT-qPCR experiments and a stability approach revealed lower real ERα activation by ISFs than measured in the ONE-Glo™ luciferase test system. In conclusion, the OECD protocol 455 appears unsuitable for testing ISFs due to their superinduction of luciferase and interactions with the test system, resulting in experimental artifacts. Further studies are necessary to explore structure-activity relationships within polyphenols and clarify the test system's applicability.

Project description:Simple Summary The poultry production worldwide needs to use feed additives in order to avoid disease. One of the most common diseases is coccidiosis, which affects the poultry gut. In case the disease happens, birds stop eating, which might cause their death as well as generating great losses to the farmer. Nicarbazin is one of the widely used anticoccidials to prevent coccidiosis. However, some non-compliances have been reported by the regulatory agencies, which made us explore chicken litter to verify if it was a contamination source in chicken tissues because birds have coprophagic habits. Therefore, our team conducted an experiment with three different nicarbazin treatments commonly used in commercial poultry production, under reused litter conditions. We evaluated the possible residue left from this anticoccidial in fillet and liver during 2 years. The outcomes have relevant implications: (a) litter is not a cause of contamination, allowing farmers to reuse it for economical purposes; and (b) chicken tissues are safe for human consumption. Abstract Nicarbazin (NCZ) is a worldwide used anticoccidial in poultry farming to avoid coccidiosis disease when chickens are reared on conventional poultry litter. If proper dosage and withdrawal time are not followed, the component dinitrocarbanilide (DNC) of NCZ may be present in chicken tissues, therefore posing a risk to consumers if the residues are above 200 µg/kg. Litter reuse is a common and important practice in commercial chicken production. Literature is lacking about the influence of litter reuse on DNC deposition in chicken tissues and its impact on food safety. We aimed to evaluate DNC residues in breast and liver by LC-MS/MS from broilers from an experiment with 10 consecutive flocks during 2 years. The experiment included three treatments containing NCZ in the diet (T1 = 125 mg/kg, 1–21 d; T2 = 125 mg/kg, 1–32 d; T3 = 40 mg/kg, 1–32 d). DNC residues in chicken breast at 21 d in T1 ranged from 648.8–926 µg/kg, at 32 d in T2 and T3 varied, respectively, from 232–667 µg/kg and 52–189 µg/kg. Regarding liver, DNC residues at 21 days in T1 ranged from 11,754–15,281 µg/kg, at 32 days in T2 and T3 varied, respectively, from 10,168–15,021 µg/kg and 2899–4573 µg/kg. When NCZ was withdrawn from feed, DNC residues dropped to <LOQ at 42 d in all treatments. Therefore, the reuse of poultry litter does not compromise food safety regarding DNC residues in chicken tissues, as shown herein up to 10 flocks.

Project description:Zearalenone (ZEA), a fungal mycotoxin, and its metabolite zeranol (ZAL) are known estrogen agonists in mammals, and are found as contaminants in food. Zeranol, which is more potent than ZEA and comparable in potency to estradiol, is also added as a growth additive in beef in the US and Canada. This article presents the development and application of a Physiologically-Based Toxicokinetic (PBTK) model for ZEA and ZAL and their primary metabolites, zearalenol, zearalanone, and their conjugated glucuronides, for rats and for human subjects. The PBTK modeling study explicitly simulates critical metabolic pathways in the gastrointestinal and hepatic systems. Metabolic events such as dehydrogenation and glucuronidation of the chemicals, which have direct effects on the accumulation and elimination of the toxic compounds, have been quantified. The PBTK model considers urinary and fecal excretion and biliary recirculation and compares the predicted biomarkers of blood, urinary and fecal concentrations with published in vivo measurements in rats and human subjects. Additionally, the toxicokinetic model has been coupled with a novel probabilistic dietary exposure model and applied to the Jersey Girl Study (JGS), which involved measurement of mycoestrogens as urinary biomarkers, in a cohort of young girls in New Jersey, USA. A probabilistic exposure characterization for the study population has been conducted and the predicted urinary concentrations have been compared to measurements considering inter-individual physiological and dietary variability. The in vivo measurements from the JGS fall within the high and low predicted distributions of biomarker values corresponding to dietary exposure estimates calculated by the probabilistic modeling system. The work described here is the first of its kind to present a comprehensive framework developing estimates of potential exposures to mycotoxins and linking them with biologically relevant doses and biomarker measurements, including a systematic characterization of uncertainties in exposure and dose estimation for a vulnerable population.

Dataset Information

Dispositions and tissue residue of zearalenone and its metabolites ?-zearalenol and ?-zearalenol in broilers.

Publications

Dispositions and tissue residue of zearalenone and its metabolites α-zearalenol and β-zearalenol in broilers.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets